Skip to main content
Erschienen in:

Open Access 04.01.2021 | Original Article

Comparison of left ventricle mechanical dyssynchrony parameters in ischemic and non-ischemic patients using 13N-NH3 PET/CT

verfasst von: Angelica Mazzoletti, Domenico Albano, Francesco Bertagna, Claudio Tinoco Mesquita, Raffaele Giubbini

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 3/2022

Abstract

Background-Aim

The relationship between perfusion pattern and stress-induced changes in Left Ventricular Mechanical Dyssynchrony (LVMD) has been previously described with controversial results using stress-rest perfusion imaging studies. The aim of this study was to assess the relationship between perfusion pattern and stress-induced changes in LVMD usingo regadenoson/rest13N-NH3 PET/CT.

Methods

There were 74 patients who underwent stress-rest 13N-NH PET/CT from January 2014 to October 2018 excluding patients with left bundle branch block, ventricular pacing and myocardial necrosis. The patients were divided into those with reversible perfusion defects at stress (Ischemic group, n = 18) and patients without reversible perfusion defects (non-ischemic group, n = 56). The LVMD parameters included: phase standard deviation (PSD) and phase histogram bandwidth (PHB), after stress and at rest. The ΔPSD (post-stressPSD-restPSD) and ΔPHB (post-stressPHB—restPHB) were calculated to measure stress-induced changes in LVMD.

Results

There were no significant differences in LVMD parameters between post-stress and at rest in both groups. The PSD post-stress, ΔPSD and PHB post-stress were significantly higher in the ischemic group.

Conclusions

Using a vasodilator as a stress, the PSD and PHB post-stress and ΔPSD were significantly higher in the ischemic patients than the non-ischemic group, while there were no significant differences in each cohort between stress and rest indices.
Begleitmaterial
Hinweise

Supplementary Information

The online version of this article (https://​doi.​org/​10.​1007/​s12350-020-02466-w) contains supplementary material, which is available to authorized users.
The authors of this article have provided a PowerPoint file, available for download at SpringerLink, which summarises the contents of the paper and is free for re-use at meetings and presentations. Search for the article DOI on SpringerLink.com.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Left ventricular mechanical dyssynchrony (LVMD) is defined as the differences in the timing of onset of contraction between the different myocardial segments and it may have prognostic value for risk stratification.1,2 LVMD by phase analysis of gated myocardial perfusion imaging (MPI) has emerged as a robust, automated, and reproducible technique to quantify mechanical dispersion.3 13N-ammonia (13N-NH3) may be used in PET/TC imaging and allows quantification of coronary flow reserve (CFR), myocardial blood flow (MBF) LV perfusion, wall motion, LV function and LVMD in patients with Coronary artery disease (CAD). Previous studies46 with different radiotracers such as Rubidium-82 and 99mTc-sestamibi, demonstrated that stress-induced ischemia causes dyssynchronous contraction in the ischemic region, leading to worsening of LVMD, but no previous study has examined the use of 13N-NH3. The aim of this study was to evaluate the relationship between perfusion pattern and stress-induced changes in LVMD using 13N-NH3 PET/CT after regadenoson stress and at rest.

Methods

PET/CT Imaging and Interpretation

Patients were in fasting state for stress studies. Maximal vasodilatation was obtained after I.V. injection of 400 mg of regadenoson over 10 seconds in the right antecubital vein followed by a bolus administration of a standard dose of 370 MBq of 13NH3 40 seconds after the end of regadenoson injection. The PET studies were acquired in 3D and list mode for 10 minutes starting acquisition immediately before 13NH3 injection by a discovery PET/CT 690 (GE Healthcare, Milwaukee, h Wisconsin, USA). A low-dose CT attenuation correction (140 kV, 120-150 mA) was acquired for optimal imaging position on a CT scout scan and for attenuation correction. PET images were corrected for attenuation. The reconstruction was performed using iterative algorithms OSEM (Ordered-subset expectation maximization) with 3 iterations and 24 subsets, filter cut-off 6 mm and 128 × 128-pixel matrix). Gated images were reconstructed in 16 bins and the dynamic images and in 32 frames for both stress and rest (24 × 10s, 4 × 30s, 4 × 60s). The perfusion pattern was assessed after iterative reconstruction of tomographic slices and evaluated as recommended by the American Society of Nuclear Cardiology. The SDS was determined by 4-DM Corridor software package (INVIA, Ann Arbor, Michigan), using an Institutional gender-matched normal database. We calculated the SSS and the SRS as the sum of the respective scores of all 17 segments, and derived SDS as the difference between SSS and SRS, served as a measure of reversibility. A SDS ≤ 1 was considered as normal.7 Aminophylline was injected at the end of the stress part (240 mg in 10 mL). Stress examination was performed with continuous ECG monitoring to assess heart rate increase induced by regadenoson stimulation. Two hours after the stress examination, rest studies were acquired for 10 minutes in 3D and list mode after the injection of a standard dose of 370 MBq of 13N-NH3. Quantitative MBF and CFR were determined using the PMOD software package (PMOD Technologies Ltd., Zurich, Switzerland). The CFR was calculated as the ratio of hyperemic to resting MBF; CFR e” 2.5 was considered as normal. The SDS as well as the MBF and CRF was evaluated for the global left ventricle (LV) and for the three coronary territories using a 17-segment model according to the American Society of Nuclear Cardiology recommendations. The PMode software package provides automatically measures of rest, stress MBF, and CFR for global, segmental (according to the 17 segment model), and for the three main vascular territories, identified as anterior, anteroseptal, and apical segments for the left anterior descending coronary artery, inferior and infero-septal segments for the right coronary artery, and of lateral segments for the left circumflex, respectively.

Patient Features

Seventy-four patients (44 men; 30 women), average age 62 ± 12.,72 (range 36-89) who had stress-rest 13N-NH3 PET/CT from January 2014 to October 2018 at our department were enrolled. Patients with left bundle branch block, ventricular pacing, previous revascularization and myocardial necrosis were excluded from the study. Patients were divided into two groups accordingly MPI results: those with reversible myocardial perfusion defects at stress (ischemic group, n. 18) and those without reversible perfusion defects (non ischemic group, n. 56). In each group, we compared the demographics such as age, sex, smoke history, obesity (evaluated as BMI >30), history of hypertension, diabetes, hyperlipidemia and kidney failure. LVMD parameters included phase histogram bandwidth (PHB) and phase standard deviation (PSD). PHB represents the range of degrees of the cardiac cycle during which 95% of myocardium is starting to contract; PSD is the standard deviation of the range. The ΔPSD (evaluated as the difference between post- stress PSD and rest PSD) and ΔPHB (- the difference between post- stress PHB and PHB at rest) were calculated to measure stress-induced changes in LVMD.

Statistical Analysis

Statistical analyses were performed out using MedCalc Software version 18.1. The descriptive analysis of categorical variables are characterized by the calculation of simple and relative frequencies, while the numeric variables by median, mean, minimum and maximum values.
Either student’s t test or Mann–Whitney test was used to compare quantitative data between different groups, when required. Chi square (χ2) test was used to compare proportions. A P value < 0.05 was considered to indicate statistical significance.

Results

The demographics are in Table 1. Non significant differences were observed between ischemic and non-ischemic groups except of sex and history of diabetes. The LVMD parameters are in Table 2. The LVMD parameters (PSD and PHB) were not significant differences between stress and rest in each group. All LVMD parameters were higher in the ischemic patients compared to non- ischemic ones, but only PSD post- stress—ΔPSD—and PHB post stress were statistically significant. The correlation matrix between LVMD and perfusion pattern is shown in Table 3. Examples from both groups are shown in Figures 1 and 2.
Table 1
Epidemiological and clinical parameters between ischemic and non-ischemic patients
 
Ischemic group (18)
Non ischemic group (56)
P Value
Average age
67±18
63 ± 13
 
Men
15/18
29/56
0.017
Women
3/18
27/56
Hypertension
9/18
34/56
0.29
Hyperlipidemia
9/18
28/56
0.5
Diabetes
6/18
9/56
0.04
BMI>30
3/18
7/56
0.39
Kidney failure
1/18
2/56
 
Smoke
3/18
14/56
0.68
Smoke in the past
5/18
16/56
0.45
Table 2
Left ventricle mechanical dyssynchrony parameters between ischemic and non-ischemic patients
 
Ischemic group (18)
Non ischemic group (56)
P Value
PSD stress
6.01±6.57
4.16±2.68
0.003
PSD rest
4.6±2.8
4.28±1.06
0.48
ΔPSD
1.41±3.74
− 0.11±1.62
0.003
PHB stress
24.22±32.52
17.46±7.07
0.008
PHB rest
18.55±14.14
15.67±5.65
0.09
ΔPHB
5.66±18.38
1.78±1.41
0.07
MBF stress
1.9±0.03
2.4±3.4
0.04
Table 3
Correlation between dyssynchrony parameters with perfusion parameters in different groups
 
Entire population n 74
Ischemic group n 18
Non-ischemic group n 56
Correlation coefficient
P Value
Correlation coefficient
P Value
Correlation coefficient
P Value
PSD stress vs SSS
0.264
0.059
− 0.001
0.998
0.294
0.098
PHB stress vs SSS
0.227
0.064
− 0.036
0.890
0.276
0.056
ΔPSD vs SDS
0.134
0.277
0.021
0.934
− 0.174
0.224
ΔPHB vs SDS
0.178
0.148
0.080
0.759
0.064
0.657
ΔPSD vs CFR
− 0.134
0.252
− 0.372
0.128
0.083
0.536
ΔPHB vs CFR
− 0.120
0.306
− 0.221
0.377
− 0.012
0.928

Discussion

Intraventricular dyssynchrony reflects inhomogeneous timing of contraction of different myocardial segments, caused by disturbed myocyte stimulation or impaired contractility.8,9 It is helpful to recognize that even structurally normal hearts exhibit some degree of non-uniformity in contraction due to its complex spatial and geometric architecture. Contraction movements depend on the complex distribution of myocardial fibers within the epicardial and endocardial regions as they are oriented longitudinally through the long axis of the heart and circumferentially within the mid-wall region. This arrangement allows for a complex contractile movement which involves both longitudinal and circumferential fibers from apex to base during systolic activation. Due to this complex fiber architecture and to the presence of His-Purkinje system, which allow electrical activation, systolic contraction can be well executed allowing efficient pump function. It is not surprising that in an ischemic heart abnormal temporal electrical activation of the complex myocardial fiber architecture reduces pump efficiency and cardiac performance.8 As a result of that abnormal activation loading, LVMD parameters increase and reflects a balance of forces, with the region that is activated early being unable to withstand the stress generated by the late-activated LV segments.1012 The regional wall contractions are not effectively converted to pressure build-up in the left ventricle, but rather cause substantial blood volume shifts within the LV cavity. The overall result is a decrease in LV pumping efficiency.912 Several new imaging techniques are proving useful for diagnosis of LV dyssynchrony and PET/TC represents a useful method to quantify LVMD parameters. Different radiotracers allow the study of both myocardial perfusion and myocardial metabolism such as radioactive 13N-NH3, H2O15, 82Rb. While water is freely diffusible without being retained from myocardial tissue, ammonia and rubidium present different pharmacokinetic features and they are usually retained in the myocardial tissue depending on myocardial blood flow. While rubidium crosses the myocyte cell membrane mainly by active diffusion, ammonia crosses the myocyte cell membrane by passive diffusion. Unlike technetium radiotracers, ammonia-PET/CT images are acquired immediately after stress induction by regadenoson injection, at maximum peak of vascular dilatation and it allow for the evaluation of absolute myocardial perfusion and mechanical synchrony at real peak hyperemic stress. Myocardial extraction of the PET/TC radiotracers at rest is higher than the radiotracers used with SPECT and it depends on myocardial blood flow. When compared to adenosine, regadenoson has been shown to be non-inferior for identifying perfusion defects13 and providing prognostic data.1419 Our study shows that LVMD is different in ischemic and non-ischemic patients though in each group they were comparable at rest and post stress. The study has limitations as it is retrospective and the ischemic group has small number of patients. However, it is a proof of principle that our protocol could be used to study LVMD in addition to other variables such as perfusion, function and MBF.

New Knowledge Gained

13N-NH3 PET/TC represent a reliable method for estimating myocardial dyssynchrony parameters. The presence of ischemia is confirmed by a non-synchronous contraction of myocardial tissue and a decrease of myocardial blood flow, parameters evaluated after pharmacological stress test conducted with the use of regadenoson.

Disclosure

The Authors do not have any conflict of interest to declare.

Ethical standards

This human study has been approved by the institutional ethics committee and has therefore been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.
All persons gave their informed consent prior to their inclusion in the study.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

© Springer Medizin

e.Med Innere Medizin

Kombi-Abonnement

Mit e.Med Innere Medizin erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Innere Medizin, den Premium-Inhalten der internistischen Fachzeitschriften, inklusive einer gedruckten internistischen Zeitschrift Ihrer Wahl.

© Springer Medizin

e.Med Radiologie

Kombi-Abonnement

Mit e.Med Radiologie erhalten Sie Zugang zu CME-Fortbildungen des Fachgebietes Radiologie, den Premium-Inhalten der radiologischen Fachzeitschriften, inklusive einer gedruckten Radiologie-Zeitschrift Ihrer Wahl.

© Springer Medizin

Anhänge

Electronic supplementary material

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Nagueh SF. Mechanical dyssynchrony in congestive heart failure: diagnostic and therapeutic implications. J Amer Coll Cardiol. 2008;51:18–22.CrossRef Nagueh SF. Mechanical dyssynchrony in congestive heart failure: diagnostic and therapeutic implications. J Amer Coll Cardiol. 2008;51:18–22.CrossRef
2.
Zurück zum Zitat Shah AM, Solomon SD. Mechanical dyssynchrony: a risk factor but not a target. Eur Heart J. 2016;37:60–2.CrossRef Shah AM, Solomon SD. Mechanical dyssynchrony: a risk factor but not a target. Eur Heart J. 2016;37:60–2.CrossRef
3.
Zurück zum Zitat Chen J, Garcia EV, Bax JJ, et al. SPECT myocardial perfusion imaging for the assessment of left ventricular mechanical dyssynchrony. J Nucl Cardiol. 2011;18:685–94.CrossRef Chen J, Garcia EV, Bax JJ, et al. SPECT myocardial perfusion imaging for the assessment of left ventricular mechanical dyssynchrony. J Nucl Cardiol. 2011;18:685–94.CrossRef
10.
Zurück zum Zitat Prinzen FW, et al. Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol. 1999;33:1735–42.CrossRef Prinzen FW, et al. Mapping of regional myocardial strain and work during ventricular pacing: experimental study using magnetic resonance imaging tagging. J Am Coll Cardiol. 1999;33:1735–42.CrossRef
11.
Zurück zum Zitat Spragg DD, et al. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation. 2003;108:929–32.CrossRef Spragg DD, et al. Regional alterations in protein expression in the dyssynchronous failing heart. Circulation. 2003;108:929–32.CrossRef
12.
Zurück zum Zitat Kass D. Ventricular resynchronization: pathophysiology and identification of responders. Rev Cardiovasc Med. 2003;4:S3–13.PubMed Kass D. Ventricular resynchronization: pathophysiology and identification of responders. Rev Cardiovasc Med. 2003;4:S3–13.PubMed
13.
Zurück zum Zitat Iskandrian AE, Bateman TM, Belardinelli L, et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol. 2007;14:645–58.CrossRef Iskandrian AE, Bateman TM, Belardinelli L, et al. Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial. J Nucl Cardiol. 2007;14:645–58.CrossRef
14.
Zurück zum Zitat Iqbal FM, Hage FG, Ahmed A, et al. Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching. JACC Cardiovasc Imaging. 2012;5:1014–21.CrossRef Iqbal FM, Hage FG, Ahmed A, et al. Comparison of the prognostic value of normal regadenoson with normal adenosine myocardial perfusion imaging with propensity score matching. JACC Cardiovasc Imaging. 2012;5:1014–21.CrossRef
15.
Zurück zum Zitat Bhatti S, Hakeem A, Dhanalakota S, et al. Prognostic value of regadenoson myocardial single-photon emission computed tomography in patients with different degrees of renal dysfunction. Eur Heart J Cardiovasc Imaging. 2014;15:933–40.CrossRef Bhatti S, Hakeem A, Dhanalakota S, et al. Prognostic value of regadenoson myocardial single-photon emission computed tomography in patients with different degrees of renal dysfunction. Eur Heart J Cardiovasc Imaging. 2014;15:933–40.CrossRef
16.
Zurück zum Zitat Hage FG, Ghimire G, Lester D, et al. The prognostic value of regadenoson myocardial perfusion imaging. J Nucl Cardiol. 2015;22:1214–21.CrossRef Hage FG, Ghimire G, Lester D, et al. The prognostic value of regadenoson myocardial perfusion imaging. J Nucl Cardiol. 2015;22:1214–21.CrossRef
17.
Zurück zum Zitat Farzaneh-Far A, Shaw LK, Dunning A. Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging. J Nucl Cardiol. 2015;22:600–7.CrossRef Farzaneh-Far A, Shaw LK, Dunning A. Comparison of the prognostic value of regadenoson and adenosine myocardial perfusion imaging. J Nucl Cardiol. 2015;22:600–7.CrossRef
18.
Zurück zum Zitat El-Hajj S, AlJaroudi WA, Farag A, et al. Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients. J Nucl Cardiol. 2016;23:101–12.CrossRef El-Hajj S, AlJaroudi WA, Farag A, et al. Effect of changes in perfusion defect size during serial regadenoson myocardial perfusion imaging on cardiovascular outcomes in high-risk patients. J Nucl Cardiol. 2016;23:101–12.CrossRef
19.
Zurück zum Zitat Doukky R, Fughhi I, Campagnoli T, et al. The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol. 2017;24:112–8.CrossRef Doukky R, Fughhi I, Campagnoli T, et al. The prognostic value of regadenoson SPECT myocardial perfusion imaging in patients with end-stage renal disease. J Nucl Cardiol. 2017;24:112–8.CrossRef
Metadaten
Titel
Comparison of left ventricle mechanical dyssynchrony parameters in ischemic and non-ischemic patients using 13N-NH3 PET/CT
verfasst von
Angelica Mazzoletti
Domenico Albano
Francesco Bertagna
Claudio Tinoco Mesquita
Raffaele Giubbini
Publikationsdatum
04.01.2021
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 3/2022
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-020-02466-w

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Kardiologie

Lohnt sich Blutdrucksenkung unter 120 mmHg?

Eine Metaanalyse von fünf klinischen Studien bestätigt: Eine intensive Blutdrucksenkung unter systolisch 120 mmHg geht mit einer geringeren Mortalität und weniger kardiovaskulären Ereignissen einher als eine Senkung unter 140 mmHg. Allerdings nimmt das Risiko für Nebenwirkungen bei intensiver Blutdrucksenkung deutlich zu.

Vorhofflimmern plus KHK: Die optimale antithrombotische Langzeittherapie

Antikoagulation allein oder in Kombination mit einem Plättchenhemmer – was ist bei Koexistenz von KHK und Vorhofflimmern die optimale antithrombotische Langzeittherapie? Eine neue Metaanalyse könnte bei der Entscheidung hilfreich sein.

Periprozeduraler Myokardschaden nach NSTEMI prognostisch bedeutsam

Erleiden NSTEMI-Patienten und -Patientinnen infolge einer PCI Myokardschädigungen mit oder ohne Infarkt, erhöht das die Gesamtmortalität und das Risiko für weitere schwere Herzereignisse. Dafür sprechen zumindest Daten aus zwei italienischen Zentren.

Blutung unter Antikoagulation: Nach maligner Ursache suchen!

Wenn ältere Menschen mit Vorhofflimmern unter oraler Antikoagulation eine Blutung erleiden, sollte die nicht vorschnell als iatrogene Komplikation eingeordnet werden: Die Blutung kann das erste Zeichen einer Krebserkrankung sein.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.